PT2655363T - Formas cristalinas e processos para a sua preparação - Google Patents

Formas cristalinas e processos para a sua preparação

Info

Publication number: PT2655363T
Authority: PT; Portugal
Prior art keywords: processes; preparation; crystalline forms; crystalline; forms
Prior art date: 2010-12-22

Application number

PT118111848T

Other languages

English (en)

Inventor

Beliaev Alexander

Alexander Learmonth David

Broadbelt Brian

Albert Ekaterina

Ndres Patricia

Original Assignee

Bial-Portela & Ca S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-12-22

Filing date

2011-12-21

Publication date

2017-07-13

2011-12-21 Application filed by Bial-Portela & Ca S A filed Critical Bial-Portela & Ca S A

2017-07-13 Publication of PT2655363T publication Critical patent/PT2655363T/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

PT118111848T 2010-12-22 2011-12-21 Formas cristalinas e processos para a sua preparação PT2655363T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201061426209P	2010-12-22	2010-12-22

Publications (1)

Publication Number	Publication Date
PT2655363T true PT2655363T (pt)	2017-07-13

Family

ID=45509613

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT118111848T PT2655363T (pt)	2010-12-22	2011-12-21	Formas cristalinas e processos para a sua preparação

Country Status (12)

Country	Link
US (1)	US8865913B2 (pt)
EP (1)	EP2655363B1 (pt)
JP (1)	JP6161538B2 (pt)
KR (1)	KR101941467B1 (pt)
CN (1)	CN103380128B (pt)
AU (1)	AU2011345467B2 (pt)
BR (1)	BR112013015864B1 (pt)
CA (1)	CA2822681C (pt)
ES (1)	ES2632351T3 (pt)
PT (1)	PT2655363T (pt)
RU (1)	RU2604734C2 (pt)
WO (1)	WO2012087174A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2604734C2 (ru)	2010-12-22	2016-12-10	БИАЛ-ПОРТЕЛА энд КА., С.А.	Кристаллическая форма и способ ее очистки
US10318138B2 (en) *	2011-03-11	2019-06-11	Intelligent Agricultural Solutions Llc	Harvesting machine capable of automatic adjustment
LT2919780T (lt) *	2012-11-14	2018-11-12	Bial - Portela & Ca., S.A.	1,3-dihidroimidazol-2-tiono dariniai, skirti panaudoti gydant plautinę arterinę hipertenziją ir plaučių pažeidimą

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE56007T1 (de) *	1984-06-22	1990-09-15	Beecham Group Plc	Wirksame benzopyranverbindungen.
US7125904B2 (en) *	2002-10-11	2006-10-24	Portela & C.A., S.A.	Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
GB2393958A (en) *	2002-10-11	2004-04-14	Portela & Ca Sa	Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase
GB0708818D0 (en) *	2007-05-08	2007-06-13	Portela & Ca Sa	Compounds
RU2604734C2 (ru)	2010-12-22	2016-12-10	БИАЛ-ПОРТЕЛА энд КА., С.А.	Кристаллическая форма и способ ее очистки

2011
- 2011-12-21 RU RU2013133822/04A patent/RU2604734C2/ru active
- 2011-12-21 ES ES11811184.8T patent/ES2632351T3/es active Active
- 2011-12-21 JP JP2013546063A patent/JP6161538B2/ja not_active Expired - Fee Related
- 2011-12-21 WO PCT/PT2011/000046 patent/WO2012087174A2/en not_active Ceased
- 2011-12-21 BR BR112013015864-6A patent/BR112013015864B1/pt not_active IP Right Cessation
- 2011-12-21 CA CA2822681A patent/CA2822681C/en active Active
- 2011-12-21 KR KR1020137019000A patent/KR101941467B1/ko not_active Expired - Fee Related
- 2011-12-21 AU AU2011345467A patent/AU2011345467B2/en not_active Ceased
- 2011-12-21 PT PT118111848T patent/PT2655363T/pt unknown
- 2011-12-21 EP EP11811184.8A patent/EP2655363B1/en not_active Not-in-force
- 2011-12-21 CN CN201180068189.2A patent/CN103380128B/zh not_active Expired - Fee Related
2013
- 2013-06-19 US US13/922,085 patent/US8865913B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR101941467B1 (ko)	2019-01-23
AU2011345467A1 (en)	2013-07-11
JP6161538B2 (ja)	2017-07-12
KR20140021533A (ko)	2014-02-20
EP2655363B1 (en)	2017-04-12
EP2655363A2 (en)	2013-10-30
WO2012087174A2 (en)	2012-06-28
BR112013015864B1 (pt)	2021-11-09
RU2604734C2 (ru)	2016-12-10
ES2632351T3 (es)	2017-09-12
RU2013133822A (ru)	2015-01-27
CN103380128A (zh)	2013-10-30
CN103380128B (zh)	2017-03-01
JP2014501255A (ja)	2014-01-20
CA2822681C (en)	2020-07-14
BR112013015864A2 (pt)	2018-06-05
CA2822681A1 (en)	2012-06-28
AU2011345467B2 (en)	2017-02-16
WO2012087174A3 (en)	2013-05-10
US20140031561A1 (en)	2014-01-30
US8865913B2 (en)	2014-10-21

Publication	Publication Date	Title
GB201001075D0 (en)	2010-03-10	Crystalline forms
DK2786756T3 (en)	2020-04-27	Kombinationsterapi med en topoisomeraseinhibitor
EP2523664A4 (en)	2013-06-26	COMPOUNDS AND METHODS
EP2657188A4 (en)	2016-11-09	FLUOROGRAPHIC AND METHOD FOR PREPARING THE SAME
PL2571863T3 (pl)	2016-03-31	Sole nilotynibu i ich postacie krystaliczne
EP2523559A4 (en)	2013-11-06	COMPOUNDS AND METHODS
SI2545048T1 (sl)	2014-12-31	Soli Raltegravirja in njegove kristalinične oblike
IL225308A0 (en)	2013-06-27	Crystalline capture of naloxol - peg
PL2578595T3 (pl)	2017-10-31	Krystaliczna lewoizowalerylospiramycyna I
EP2523560A4 (en)	2013-07-03	CONNECTIONS AND METHODS
ZA201207343B (en)	2013-06-26	Fastener
PL2627917T3 (pl)	2016-12-30	Łącznik z trzpieniem
ZA201305277B (en)	2014-09-25	Phenyl-isoxazol derivatives and preparation process thereof
EP2596007A4 (en)	2014-07-30	PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
ZA201300546B (en)	2018-12-19	Process for the preparation of 3-haloalkylpyrazoles
PT2655363T (pt)	2017-07-13	Formas cristalinas e processos para a sua preparação
TWM433166U (en)	2012-07-11	Pillow
PT2390246T (pt)	2018-11-30	Processo para a preparação de aminaftona
ZA201108148B (en)	2012-12-27	Triazine-aryl-bis-indoles and process for preparation thereof
IL223436A (en)	2016-11-30	Methods for preparing tetranor - pgdm and tetranor - pgjm
GB201301307D0 (en)	2013-03-06	Crystalline form of prulifloxacin and processes for its preparation
GB201119674D0 (en)	2011-12-28	Fastener
PL2598504T3 (pl)	2014-10-31	Sposób otrzymywania dimiracetamu
GB201003853D0 (en)	2010-04-21	Improvements in crystallisation
GB201009684D0 (en)	2010-07-21	Odontalgic preparation